Literature DB >> 2477090

Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats.

B Beilin1, F C Martin, Y Shavit, R P Gale, J C Liebeskind.   

Abstract

Suppression of natural killer (NK) cell activity in the postoperative period has been reported in several clinical studies. Endogenous opioids and cerebral injection of morphine have been shown to suppress NK cell activity. Since high-dose opiates are commonly used in anesthetic practice, we sought to determine the effects of three narcotic agents on NK cell activity. Male rats were injected subcutaneously with morphine (30 mg/kg), fentanyl (0.3 mg/kg), or sufentanil (0.06 mg/kg). Three, 12, or 24 h later the cytotoxic activity of splenic NK cells was measured in a 4-h chromium-51 release assay using radiolabeled target cells. All three drugs significantly suppressed NK cytotoxicity at 3 h after administration; this effect was blocked by an opiate antagonist, naltrexone. Fentanyl and sufentanil also caused a significant suppression 12 h after drug administration. By 24 h NK activity of all groups returned to normal values. Interferon is known to augment NK cell activity. Therefore, in another experiment rats were given an interferon inducer, polyinosinic:polycytidylic acid (poly I:C), to determine if it would alter the effects of these narcotics on splenic NK activity. Poly I:C treatment increased NK cytotoxicity to above baseline; fentanyl in these animals reduced NK activity and brought it back to control levels. These findings suggest that clinically used high-dose narcotic anesthesia can suppress NK cytotoxic activity and that pretreatment with interferon can attenuate this suppression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477090     DOI: 10.1016/0889-1591(89)90013-5

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  13 in total

1.  Suppression of Human Natural Killer Cells by Different Classes of Opioids.

Authors:  Dermot P Maher; Deepa Walia; Nicola M Heller
Journal:  Anesth Analg       Date:  2019-05       Impact factor: 5.108

Review 2.  Opioids and the immune system - friend or foe.

Authors:  Lisanne Mirja Plein; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

Review 3.  [Influence of anesthesia procedure on malignant tumor outcome].

Authors:  K Fukui; C Werner; G Pestel
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

4.  Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase.

Authors:  D T Lysle; K A Carrigan
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

5.  Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study.

Authors:  Sascha Dublin; Rod L Walker; Michael L Jackson; Jennifer C Nelson; Noel S Weiss; Michael Von Korff; Lisa A Jackson
Journal:  J Am Geriatr Soc       Date:  2011-09-13       Impact factor: 5.562

Review 6.  Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients.

Authors:  Alan David Kaye; Nayan Patel; Franklin Rivera Bueno; Brad Hymel; Nalini Vadivelu; Gopal Kodumudi; Richard D Urman
Journal:  Ochsner J       Date:  2014

Review 7.  NK cells in the tumor microenvironment.

Authors:  Stine K Larsen; Yanhua Gao; Per H Basse
Journal:  Crit Rev Oncog       Date:  2014

8.  The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies.

Authors:  Wan-Kun Chen; Chang-Hong Miao
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Segmental thoracic spinal has advantages over general anesthesia for breast cancer surgery.

Authors:  Mohamed Hamdy Elakany; Sherif Ahmed Abdelhamid
Journal:  Anesth Essays Res       Date:  2013 Sep-Dec

10.  Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial.

Authors:  Lijian Pei; Yidong Zhou; Gang Tan; Feng Mao; Dongsheng Yang; Jinghong Guan; Yan Lin; Xuejing Wang; Yanna Zhang; Xiaohui Zhang; Songjie Shen; Zhonghuang Xu; Qiang Sun; Yuguang Huang
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.